India’s biotechnology sector to reach $300 billion by 2030

The government had launched the Biopharma Mission at the national level, while other programs included Bio AI Hubs, Bio Agriculture and Bioenergy, Prof. Sopory said while addressing the inaugural session of the three-day International Conference on ‘Biotechnology for Sustainable Development and Circular Economy’ at the SOA Deemed to be University here.

India’s biotechnology sector to reach $300 billion by 2030

Photo: SNS

India’s bioeconomy, which includes biotech, pharma and agriculture, officially valued at 165 billion dollars in 2024, was expected to reach 300 billion dollars by 2030, Prof. Sudhir Kumar Sopory, president of the Biotech Research Society, India (BRSI), said on Monday.

The government had launched the Biopharma Mission at the national level, while other programs included Bio AI Hubs, Bio Agriculture and Bioenergy, Prof. Sopory said while addressing the inaugural session of the three-day International Conference on ‘Biotechnology for Sustainable Development and Circular Economy’ at the SOA Deemed to be University here.

Advertisement

The National Biopharma Mission is an industry-academia collaborative mission for accelerating biopharmaceutical development in the country, under which the government has launched programs to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing.

Advertisement

The conference, which is being attended by 40 eminent scientists from 28 different countries, has been organised by the Centre for Industrial Biotechnology Research (CIBR) of SOA in collaboration with the BRSI.

Prof. Ashish Ghosh, Director of the Indian Institute of Information Technology (IIIT) Bhubaneswar, who graced the program as the chief guest, focused on the use of biotech for the betterment of human society.

“Whatever has happened is for transformation, which has been a big boost for improving the quality of human life, and most of these transformations have come from the biotech sector,” he said while pointing out that most of the vaccines invented so far have been biotech products, including the vaccine against the Covid-19 infection.

The conference, he hoped, would serve as a platform for intense discussion on how to use biotech for the good of humanity.

The International Bio-processing Association (IBA) awards were presented to Prof. A.A. Koutinas of the University of Patras, Greece, and Prof. Suzana Ferreira Dias of the University of Agriculture, Lisbon, Portugal. Prof. Koutinas was honoured for his work in the field of Food Biotechnology, while Prof. Dias was given the award for her research in the field of Food Engineering.

 

Advertisement